Evidence map›Paper›PMID 33998886›Full record

ArticleCannabis and cannabinoid research2022

Synthetic Cannabinoid-Related Deaths in England, 2012-2019.

Pruntha Yoganathan, Hugh Claridge, Lucy Chester, Amir Englund, Nicola J Kalk, Caroline S Copeland

Open access · greenAbstract read
In one paragraph

Article in Cannabis and cannabinoid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. An Internet Snapshot Survey Assessing the sale of Synthetic Cannabinoid Receptor Agonists for use with Electronic Vaping Devices.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  10. Cardiac effects of 5F-Cumyl-PEGACLONE.International journal of legal medicine · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pruntha YoganathanPopulation Health Research Institute, St George's, University of London, London, United Kingdom.
Hugh ClaridgePopulation Health Research Institute, St George's, University of London, London, United Kingdom.
Lucy ChesterDepartment of Psychosis Studies and Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Amir EnglundDepartment of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Nicola J KalkDepartment of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Caroline S CopelandPopulation Health Research Institute, St George's, University of London, London, United Kingdom.
King's College London · GBSt George's, University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabinoidsIll-Housed PersonsSubstance-Related DisordersCannabinoid Receptor AgonistsEnglandFemaleHumansMaleCannabinoid Receptor AgonistsCannabinoidscannabinoiddrug-related deathnovel psychoactive substancespicesubstance abusesynthetic cannabinoid receptor agonist

Identifiers

PMID33998886
PMCPMC9418359
OpenAlexW3133771337

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.